Search

Zoetis Inc

Geschlossen

BrancheGesundheitswesen

75.98 -1.43

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

76.83

Max

79.78

Schlüsselkennzahlen

By Trading Economics

Einkommen

-2M

601M

Verkäufe

-125M

2.3B

KGV

Branchendurchschnitt

12.61

64.641

EPS

1.53

Dividendenrendite

2.69

Gewinnspanne

26.569

Angestellte

14,500

EBITDA

-8M

939M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+28.58% upside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

2.69%

2.31%

Nächstes Ergebnis

6. Aug. 2026

Nächste Dividendenausschüttung

1. Sept. 2026

Nächstes Ex-Dividendendatum

30. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-16B

32B

Vorheriger Eröffnungskurs

77.41

Vorheriger Schlusskurs

75.98

Nachrichtenstimmung

By Acuity

43%

57%

135 / 340 Ranking in Healthcare

Zoetis Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Aug. 2026, 23:31 UTC

Zoetis Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains amid favorable market sentiment.

1. Aug. 2026, 00:01 UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

31. Juli 2026, 23:06 UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

30. Juli 2026, 19:03 UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

29. Juli 2026, 22:51 UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

28. Juli 2026, 23:02 UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

27. Juli 2026, 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

25. Juli 2026, 00:01 UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

24. Juli 2026, 21:02 UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

23. Juli 2026, 20:02 UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

22. Juli 2026, 21:02 UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

21. Juli 2026, 17:51 UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

20. Juli 2026, 23:16 UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Peer-Vergleich

Kursveränderung

Zoetis Inc Prognose

Kursziel

By TipRanks

28.58% Vorteil

12-Monats-Prognose

Durchschnitt 99.38 USD  28.58%

Hoch 130 USD

Tief 85 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Zoetis Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

12 ratings

6

Buy

6

Halten

0

Sell

Stimmung

By Acuity

135 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat